{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:52:18Z","timestamp":1792457538947,"version":"4.5.0"},"reference-count":77,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJNPPY"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1093\/ijnp\/pyv102","type":"journal-article","created":{"date-parts":[[2015,9,12]],"date-time":"2015-09-12T20:28:50Z","timestamp":1442089730000},"page":"pyv102","source":"Crossref","is-referenced-by-count":128,"title":["D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review"],"prefix":"10.1093","volume":"19","author":[{"given":"Sebastian","family":"Schade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,9,12]]},"reference":[{"key":"2016042019185783000_19.4.pyv102.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2009.11.066"},{"key":"2016042019185783000_19.4.pyv102.2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1982.04290070020005"},{"key":"2016042019185783000_19.4.pyv102.3","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(94)00745-S"},{"key":"2016042019185783000_19.4.pyv102.4","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.11r07356"},{"key":"2016042019185783000_19.4.pyv102.5","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.06081358"},{"key":"2016042019185783000_19.4.pyv102.6","doi-asserted-by":"publisher","DOI":"10.1007\/s007020050076"},{"key":"2016042019185783000_19.4.pyv102.7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fpsyt.2012.00067","article-title":"Pharmacological modulation of the short-lasting effects of antagonistic direct current-stimulation over the human motor cortex","volume":"3","author":"Chaieb","year":"2012","journal-title":"Front Psychiatry"},{"key":"2016042019185783000_19.4.pyv102.8","doi-asserted-by":"publisher","DOI":"10.1152\/jn.00882.2013"},{"key":"2016042019185783000_19.4.pyv102.9","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2002.00014.x"},{"key":"2016042019185783000_19.4.pyv102.10","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0031-6997(24)01382-6","article-title":"Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications","volume":"50","author":"Danysz","year":"1998","journal-title":"Pharmacol Rev"},{"key":"2016042019185783000_19.4.pyv102.11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.31887\/DCNS.2011.13.4\/mdavis","article-title":"NMDA receptors and fear extinction: implications for cognitive behavioral therapy","volume":"13","author":"Davis","year":"2011","journal-title":"Dialogues Clin Neurosci"},{"key":"2016042019185783000_19.4.pyv102.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.03.084"},{"key":"2016042019185783000_19.4.pyv102.13","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5390-09.2010"},{"key":"2016042019185783000_19.4.pyv102.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2004.03.013"},{"key":"2016042019185783000_19.4.pyv102.15","doi-asserted-by":"publisher","DOI":"10.1177\/089198879500800405"},{"key":"2016042019185783000_19.4.pyv102.16","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.152.8.1213"},{"key":"2016042019185783000_19.4.pyv102.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(98)00367-9"},{"key":"2016042019185783000_19.4.pyv102.18","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.153.12.1628"},{"key":"2016042019185783000_19.4.pyv102.19","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.56.1.21"},{"key":"2016042019185783000_19.4.pyv102.20","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-004-2032-2"},{"key":"2016042019185783000_19.4.pyv102.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2008.08.012"},{"key":"2016042019185783000_19.4.pyv102.22","unstructured":"Goodman LS Hardman JG Limbird LE Gilman AG (2001) Goodman & Gilman\u2019s the pharmacological basis of therapeutics, 10th Edition. New York: McGraw-Hill."},{"key":"2016042019185783000_19.4.pyv102.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2011.05.029"},{"key":"2016042019185783000_19.4.pyv102.24","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-013-0399-y"},{"key":"2016042019185783000_19.4.pyv102.25","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145798001242"},{"key":"2016042019185783000_19.4.pyv102.26","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.3.480"},{"key":"2016042019185783000_19.4.pyv102.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2006.03.004"},{"key":"2016042019185783000_19.4.pyv102.28","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145712000910"},{"key":"2016042019185783000_19.4.pyv102.29","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1152\/jn.1996.75.5.1765","article-title":"Conditions for the induction of long-term potentiation in layer II\/III horizontal connections of the rat motor cortex","volume":"75","author":"Hess","year":"1996","journal-title":"J Neurophysiol"},{"key":"2016042019185783000_19.4.pyv102.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.nlm.2011.01.008"},{"key":"2016042019185783000_19.4.pyv102.31","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.12070974"},{"key":"2016042019185783000_19.4.pyv102.32","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-014-0532-2"},{"key":"2016042019185783000_19.4.pyv102.33","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(89)90379-0"},{"key":"2016042019185783000_19.4.pyv102.34","doi-asserted-by":"crossref","unstructured":"Jones R Laake K Oeksengaard AR (2002) D-cycloserine for Alzheimer\u2019s disease. The Cochrane database of systematic reviews: CD003153.","DOI":"10.1002\/14651858.CD003153"},{"key":"2016042019185783000_19.4.pyv102.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2006.12.001"},{"key":"2016042019185783000_19.4.pyv102.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropsychologia.2008.02.023"},{"key":"2016042019185783000_19.4.pyv102.37","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2008.32"},{"key":"2016042019185783000_19.4.pyv102.38","doi-asserted-by":"publisher","DOI":"10.1037\/0735-7044.117.2.341"},{"key":"2016042019185783000_19.4.pyv102.39","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0022-3565(25)20677-2","article-title":"D-cycloserine, a partial agonist at the glycine site coupled to N-methyl-D-aspartate receptors, improves visual recognition memory in rhesus monkeys","volume":"278","author":"Matsuoka","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"2016042019185783000_19.4.pyv102.40","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0022-3565(24)36478-X","article-title":"NR1 and NR2 subunit contributions to N-methyl-D-aspartate receptor channel blocker pharmacology","volume":"280","author":"Monaghan","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"2016042019185783000_19.4.pyv102.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2013.08.013"},{"key":"2016042019185783000_19.4.pyv102.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2012.02.030"},{"key":"2016042019185783000_19.4.pyv102.43","doi-asserted-by":"publisher","DOI":"10.1177\/1545968314532032"},{"key":"2016042019185783000_19.4.pyv102.44","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300517"},{"key":"2016042019185783000_19.4.pyv102.45","doi-asserted-by":"publisher","DOI":"10.1038\/nature01497"},{"key":"2016042019185783000_19.4.pyv102.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2008.01.012"},{"key":"2016042019185783000_19.4.pyv102.47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-72873-0_1","volume-title":"antituberculosis drugs","volume":"Historical introduction and chem","author":"Offe","year":"1988"},{"key":"2016042019185783000_19.4.pyv102.48","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(03)00009-1"},{"key":"2016042019185783000_19.4.pyv102.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.nlm.2005.01.001"},{"key":"2016042019185783000_19.4.pyv102.50","doi-asserted-by":"crossref","unstructured":"Peloquin CA (2008) Clinical pharmacology of the antituberculosis drugs. In: Clinical tuberculosis, Fourth Edition ( Davies PDO Barnes PF Gordon SB , eds), pp 205\u2013224. Boca Raton: CRS Press.","DOI":"10.1201\/b13468-17"},{"key":"2016042019185783000_19.4.pyv102.51","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(00)00090-3"},{"key":"2016042019185783000_19.4.pyv102.52","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.11.2115"},{"key":"2016042019185783000_19.4.pyv102.53","doi-asserted-by":"publisher","DOI":"10.3109\/00952990903384332"},{"key":"2016042019185783000_19.4.pyv102.54","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(94)90687-4"},{"key":"2016042019185783000_19.4.pyv102.55","doi-asserted-by":"publisher","DOI":"10.1097\/00002093-199408030-00006"},{"key":"2016042019185783000_19.4.pyv102.56","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(98)00810-5"},{"key":"2016042019185783000_19.4.pyv102.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.04.023"},{"key":"2016042019185783000_19.4.pyv102.58","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.2.420"},{"key":"2016042019185783000_19.4.pyv102.59","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(01)00073-9"},{"key":"2016042019185783000_19.4.pyv102.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2007.08.020"},{"key":"2016042019185783000_19.4.pyv102.61","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2014.12.004"},{"key":"2016042019185783000_19.4.pyv102.62","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3389\/fphar.2014.00229","article-title":"A computer-based quantitative systems pharmacology model of negative symptoms in schizophrenia: exploring glycine modulation of excitation-inhibition balance","volume":"5","author":"Spiros","year":"2014","journal-title":"Front Pharmacol"},{"key":"2016042019185783000_19.4.pyv102.63","doi-asserted-by":"publisher","DOI":"10.1097\/01.pra.0000281484.89075.a8"},{"key":"2016042019185783000_19.4.pyv102.64","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(88)91533-8"},{"key":"2016042019185783000_19.4.pyv102.65","doi-asserted-by":"publisher","DOI":"10.1002\/hup.1253"},{"key":"2016042019185783000_19.4.pyv102.66","doi-asserted-by":"publisher","DOI":"10.2174\/138161210790361452"},{"key":"2016042019185783000_19.4.pyv102.67","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1176\/ajp.156.3.467","article-title":"Improved cognition in Alzheimer\u2019s disease with short-term D-cycloserine treatment","volume":"156","author":"Tsai","year":"1999","journal-title":"Am J Psychiatry"},{"key":"2016042019185783000_19.4.pyv102.68","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2004.05.005"},{"key":"2016042019185783000_19.4.pyv102.69","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0000000000000033"},{"key":"2016042019185783000_19.4.pyv102.70","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.13070155"},{"key":"2016042019185783000_19.4.pyv102.71","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(99)00014-7"},{"key":"2016042019185783000_19.4.pyv102.72","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1523\/JNEUROSCI.22-06-02343.2002","article-title":"Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats","volume":"22","author":"Walker","year":"2002","journal-title":"J Neurosci"},{"key":"2016042019185783000_19.4.pyv102.73","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(92)94837-L"},{"key":"2016042019185783000_19.4.pyv102.74","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(90)90745-W"},{"key":"2016042019185783000_19.4.pyv102.75","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2007.04.010"},{"key":"2016042019185783000_19.4.pyv102.76","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(94)90132-5"},{"key":"2016042019185783000_19.4.pyv102.77","doi-asserted-by":"publisher","DOI":"10.1002\/da.22170"}],"container-title":["International Journal of Neuropsychopharmacology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T12:17:05Z","timestamp":1748607425000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijnp\/article-lookup\/doi\/10.1093\/ijnp\/pyv102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,12]]},"references-count":77,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,20]]},"published-print":{"date-parts":[[2016,4]]}},"alternative-id":["10.1093\/ijnp\/pyv102"],"URL":"https:\/\/doi.org\/10.1093\/ijnp\/pyv102","relation":{},"ISSN":["1461-1457","1469-5111"],"issn-type":[{"value":"1461-1457","type":"print"},{"value":"1469-5111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,12]]}}}